Agilon Health (AGL) Net Cash Flow (2020 - 2026)

Agilon Health (AGL) has 7 years of Net Cash Flow data on file, last reported at $37.9 million in Q1 2026.

• Quarterly Net Cash Flow rose 168.53% year-over-year to $37.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.9 million (up 263.39% YoY) and the FY2025 annual result came in at -$20.1 million, down 125.33% from the prior year.
• Net Cash Flow climbed to $37.9 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $40.1 million in Q4 2024 to a low of -$352.6 million in Q2 2022.
• A 5-year average of -$49.6 million and a median of -$18.6 million in 2022 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 1581.17% in 2025, down 1408.62% in 2025.
• Tracing AGL's Net Cash Flow over 5 years: stood at -$56.8 million in 2022, then retreated by 13.05% to -$64.2 million in 2023, then jumped by 162.4% to $40.1 million in 2024, then sank by 94.94% to $2.0 million in 2025, then surged by 1765.6% to $37.9 million in 2026.
• The last three Net Cash Flow figures came in at $37.9 million (Q1 2026), $2.0 million (Q4 2025), and $268000.0 (Q3 2025), per Business Quant data.